Adcock Ingram Integrated Report 2018

105 ADCOCK INGRAM  Integrated Report 2018 Effective Effective holding % holding % 2018 2017 2018 2017 R’000 R’000 D INVESTMENTS Adcock Ingram Limited 100 100 2 130 587 2 130 587 Adcock Ingram Healthcare Proprietary Limited 100 100 815 390 815 390 Adcock Ingram Intellectual Property Proprietary Limited 100 100 104 000 104 000 Adcock Ingram Critical Care Proprietary Limited 100 100 284 979 284 979 Adcock Ingram International Proprietary Limited 100 100 * * Tender Loving Care Hygienic, Cosmetic and Baby Products Proprietary Limited 100 100 * * Thembalami Pharmaceuticals Proprietary Limited 50 50 * * Adcock Ingram Limited India 49.9 49.9 31 930 31 930 Group Risk Holdings Proprietary Limited (1) 5.3 5.3 1 937 1 906 3 368 823 3 368 792 * Less than R1 000 (1) Group Risk Holdings Proprietary Limited Balance at 1 July 1 906 2 215 Disposal of 0.9% interest – (318) Revaluation of investment to fair value 31 9 1 937 1 906 E NET CASH AND CASH EQUIVALENTS E.1 CASH AND CASH EQUIVALENTS Cash at banks 30 809 26 121 E.2 BANK OVERDRAFT (250 000) – (219 191) 26 121 Favourable balances attract interest at 5.75%. Overdraft balances incur interest at 8.3%. F AMOUNTS OWING BY/TO GROUP COMPANIES F.1 AMOUNTS OWING BY GROUP COMPANIES Included in current assets Adcock Ingram Healthcare Proprietary Limited – 585 Adcock Ingram International Proprietary Limited 167 154 167 154 Adcock Ingram Critical Care Proprietary Limited 98 000 160 000 Adcock Ingram Holdings Limited Employee Share Trust (2008) – 3 265 154 327 742 The loans are unsecured, interest free, and have no fixed terms of repayment. F.2 AMOUNTS OWING TO GROUP COMPANIES Included in non-current liabilities Adcock Ingram Limited 2 155 994 2 155 994 Included in current liabilities Adcock Ingram Healthcare Proprietary Limited 214 158 295 334 2 370 152 2 451 328 The loans are unsecured, interest free, and have no fixed term of repayment. It is not expected that the subsidiaries would call for payment within the next 12 months. Notes to the Company annual financial statements continued